Suppr超能文献

相似文献

1
Perspectives on the management of coronary artery disease in India.
Heart. 2007 Nov;93(11):1334-8. doi: 10.1136/hrt.2007.131193.
2
Coronary artery disease in Brazil: contemporary management and future perspectives.
Heart. 2009 Jun;95(11):870-6. doi: 10.1136/hrt.2008.155853. Epub 2009 Mar 3.
4
Do Legal Issues Deserve Space in Specialty Medical Journals ?
J Assoc Physicians India. 2016 Feb;64(2):86-87.
8
The future of Cochrane Neonatal.
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
10
Left main coronary stenosis and acute myocardial infarction: stent or surgery? An evolving perspective.
Catheter Cardiovasc Interv. 2012 May 1;79(6):988-9. doi: 10.1002/ccd.24428.

引用本文的文献

1
Ceruloplasmin, Vitamin C, and Uric Acid Levels in Patients With Myocardial Infarction: A Comparative Cross-Sectional Study.
Cureus. 2024 Mar 13;16(3):e56122. doi: 10.7759/cureus.56122. eCollection 2024 Mar.
2
Cardiac rehabilitation knowledge, awareness, and practice among cardiologists in India.
Indian Heart J. 2018 Sep-Oct;70(5):753-755. doi: 10.1016/j.ihj.2018.04.011. Epub 2018 Apr 26.
3
Prevalence and pattern of cardiovascular risk factors in a population in India.
Heart Asia. 2017 Sep 14;9(2):e010931. doi: 10.1136/heartasia-2017-010931. eCollection 2017.
4
Population access to reperfusion services for ST-segment elevation myocardial infarction in Kerala, India.
Indian Heart J. 2017 Apr;69 Suppl 1(Suppl 1):S51-S56. doi: 10.1016/j.ihj.2017.02.014. Epub 2017 Mar 6.
5
Pre-hospital policies for the care of patients with acute coronary syndromes in India: A policy document analysis.
Indian Heart J. 2017 Apr;69 Suppl 1(Suppl 1):S12-S19. doi: 10.1016/j.ihj.2016.06.012. Epub 2016 Jun 29.
7
Building the Case for Clopidogrel as a World Health Organization Essential Medicine.
Circ Cardiovasc Qual Outcomes. 2015 Jul;8(4):447-51. doi: 10.1161/CIRCOUTCOMES.115.001866. Epub 2015 Jun 2.
8
Global perspective on acute coronary syndrome: a burden on the young and poor.
Circ Res. 2014 Jun 6;114(12):1959-75. doi: 10.1161/CIRCRESAHA.114.302782.

本文引用的文献

1
Polypharmacotherapy for primary prevention of cardiovascular disease.
Indian Heart J. 2008 Mar-Apr;60(2 Suppl B):B29-33.
2
Coronary intervention data in India for the year 2005.
Indian Heart J. 2006 May-Jun;58(3):279-81.
3
Optimal medical therapy with or without PCI for stable coronary disease.
N Engl J Med. 2007 Apr 12;356(15):1503-16. doi: 10.1056/NEJMoa070829. Epub 2007 Mar 26.
5
Coronary intervention for persistent occlusion after myocardial infarction.
N Engl J Med. 2006 Dec 7;355(23):2395-407. doi: 10.1056/NEJMoa066139. Epub 2006 Nov 14.
8
Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study.
Lancet. 2006 Aug 19;368(9536):647-58. doi: 10.1016/S0140-6736(06)69249-0.
10
Methods for establishing a surveillance system for cardiovascular diseases in Indian industrial populations.
Bull World Health Organ. 2006 Jun;84(6):461-9. doi: 10.2471/blt.05.027037. Epub 2006 Jun 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验